nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—HPD—nephron tubule—type 2 diabetes mellitus	0.0416	0.304	CbGeAlD
Nitisinone—HPD—kidney—type 2 diabetes mellitus	0.0365	0.267	CbGeAlD
Nitisinone—HPD—cortex of kidney—type 2 diabetes mellitus	0.0356	0.26	CbGeAlD
Nitisinone—HPD—liver—type 2 diabetes mellitus	0.0231	0.169	CbGeAlD
Nitisinone—HPD—Amino acid and derivative metabolism—BHMT—type 2 diabetes mellitus	0.0201	0.0908	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—AANAT—type 2 diabetes mellitus	0.0176	0.0793	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—CDO1—type 2 diabetes mellitus	0.0166	0.0752	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—MAT1A—type 2 diabetes mellitus	0.0147	0.0662	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—CBS—type 2 diabetes mellitus	0.0115	0.0521	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—MTR—type 2 diabetes mellitus	0.00744	0.0336	CbGpPWpGaD
Nitisinone—Nilutamide—AR—type 2 diabetes mellitus	0.00654	0.341	CrCbGaD
Nitisinone—HPD—Amino acid and derivative metabolism—PSMD6—type 2 diabetes mellitus	0.0065	0.0294	CbGpPWpGaD
Nitisinone—Flutamide—AR—type 2 diabetes mellitus	0.00638	0.332	CrCbGaD
Nitisinone—Flutamide—CYP1A2—type 2 diabetes mellitus	0.00379	0.197	CrCbGaD
Nitisinone—HPD—Metabolism—BHMT—type 2 diabetes mellitus	0.00369	0.0167	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PTGDS—type 2 diabetes mellitus	0.00322	0.0146	CbGpPWpGaD
Nitisinone—HPD—Metabolism—AANAT—type 2 diabetes mellitus	0.00322	0.0146	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CDO1—type 2 diabetes mellitus	0.00306	0.0138	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GPD2—type 2 diabetes mellitus	0.00306	0.0138	CbGpPWpGaD
Nitisinone—HPD—Metabolism—AK1—type 2 diabetes mellitus	0.00292	0.0132	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SLC5A4—type 2 diabetes mellitus	0.00269	0.0122	CbGpPWpGaD
Nitisinone—HPD—Metabolism—MAT1A—type 2 diabetes mellitus	0.00269	0.0122	CbGpPWpGaD
Nitisinone—Gastroenteritis—Gliclazide—type 2 diabetes mellitus	0.00264	0.00424	CcSEcCtD
Nitisinone—Bronchitis—Sitagliptin—type 2 diabetes mellitus	0.00262	0.00421	CcSEcCtD
Nitisinone—Hepatic failure—Gliclazide—type 2 diabetes mellitus	0.00261	0.00419	CcSEcCtD
Nitisinone—HPD—Metabolism—HBA2—type 2 diabetes mellitus	0.0026	0.0117	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ENPP1—type 2 diabetes mellitus	0.0026	0.0117	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ND1—type 2 diabetes mellitus	0.0026	0.0117	CbGpPWpGaD
Nitisinone—HPD—Metabolism—G6PC—type 2 diabetes mellitus	0.0026	0.0117	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.0026	0.0117	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00257	0.00413	CcSEcCtD
Nitisinone—Conjunctivitis—Glipizide—type 2 diabetes mellitus	0.00254	0.00408	CcSEcCtD
Nitisinone—Cataract—Losartan—type 2 diabetes mellitus	0.00252	0.00404	CcSEcCtD
Nitisinone—HPD—Metabolism—GCGR—type 2 diabetes mellitus	0.00252	0.0114	CbGpPWpGaD
Nitisinone—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.00251	0.00403	CcSEcCtD
Nitisinone—Flutamide—CYP3A4—type 2 diabetes mellitus	0.00251	0.13	CrCbGaD
Nitisinone—Alopecia—Repaglinide—type 2 diabetes mellitus	0.0025	0.00402	CcSEcCtD
Nitisinone—Eye disorder—Rosiglitazone—type 2 diabetes mellitus	0.0025	0.00402	CcSEcCtD
Nitisinone—Infection—Linagliptin—type 2 diabetes mellitus	0.00247	0.00396	CcSEcCtD
Nitisinone—Thirst—Gliclazide—type 2 diabetes mellitus	0.00246	0.00395	CcSEcCtD
Nitisinone—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.00246	0.00395	CcSEcCtD
Nitisinone—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.00246	0.00395	CcSEcCtD
Nitisinone—Agranulocytosis—Glipizide—type 2 diabetes mellitus	0.00244	0.00391	CcSEcCtD
Nitisinone—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.00243	0.0039	CcSEcCtD
Nitisinone—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00241	0.00388	CcSEcCtD
Nitisinone—Hypoglycaemia—Gliclazide—type 2 diabetes mellitus	0.0024	0.00385	CcSEcCtD
Nitisinone—HPD—Metabolism—OXCT1—type 2 diabetes mellitus	0.00238	0.0107	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CYTB—type 2 diabetes mellitus	0.00238	0.0107	CbGpPWpGaD
Nitisinone—Hepatic failure—Orlistat—type 2 diabetes mellitus	0.00237	0.0038	CcSEcCtD
Nitisinone—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.00236	0.00379	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Gliclazide—type 2 diabetes mellitus	0.00234	0.00376	CcSEcCtD
Nitisinone—HPD—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00232	0.0105	CbGpPWpGaD
Nitisinone—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	0.00227	0.00365	CcSEcCtD
Nitisinone—Thirst—Orlistat—type 2 diabetes mellitus	0.00223	0.00359	CcSEcCtD
Nitisinone—HPD—Metabolism—HSD17B3—type 2 diabetes mellitus	0.00221	0.00998	CbGpPWpGaD
Nitisinone—HPD—Metabolism—STAR—type 2 diabetes mellitus	0.00221	0.00998	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ACACA—type 2 diabetes mellitus	0.00221	0.00998	CbGpPWpGaD
Nitisinone—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.00221	0.00355	CcSEcCtD
Nitisinone—Eye disorder—Glipizide—type 2 diabetes mellitus	0.00219	0.00352	CcSEcCtD
Nitisinone—Leukocytosis—Ramipril—type 2 diabetes mellitus	0.00219	0.00351	CcSEcCtD
Nitisinone—Hypoglycaemia—Orlistat—type 2 diabetes mellitus	0.00218	0.0035	CcSEcCtD
Nitisinone—Dry skin—Gliclazide—type 2 diabetes mellitus	0.00215	0.00345	CcSEcCtD
Nitisinone—HPD—Metabolism—ABCC8—type 2 diabetes mellitus	0.00212	0.00957	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CBS—type 2 diabetes mellitus	0.00212	0.00957	CbGpPWpGaD
Nitisinone—Hepatic function abnormal—Irbesartan—type 2 diabetes mellitus	0.00212	0.0034	CcSEcCtD
Nitisinone—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.0021	0.00337	CcSEcCtD
Nitisinone—Eye disorder—Pioglitazone—type 2 diabetes mellitus	0.0021	0.00337	CcSEcCtD
Nitisinone—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.00209	0.00335	CcSEcCtD
Nitisinone—Gastroenteritis—Irbesartan—type 2 diabetes mellitus	0.00209	0.00335	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00209	0.00335	CcSEcCtD
Nitisinone—Gastritis—Gliclazide—type 2 diabetes mellitus	0.00207	0.00333	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC5A2—type 2 diabetes mellitus	0.00204	0.00921	CbGpPWpGaD
Nitisinone—HPD—Metabolism—COX2—type 2 diabetes mellitus	0.00204	0.00921	CbGpPWpGaD
Nitisinone—Eye disorder—Sitagliptin—type 2 diabetes mellitus	0.00204	0.00327	CcSEcCtD
Nitisinone—Hypoglycaemia—Metformin—type 2 diabetes mellitus	0.00201	0.00322	CcSEcCtD
Nitisinone—HPD—Metabolism—NCOA6—type 2 diabetes mellitus	0.002	0.00905	CbGpPWpGaD
Nitisinone—Tension—Glipizide—type 2 diabetes mellitus	0.002	0.00322	CcSEcCtD
Nitisinone—Nervousness—Glipizide—type 2 diabetes mellitus	0.00198	0.00318	CcSEcCtD
Nitisinone—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.00197	0.00317	CcSEcCtD
Nitisinone—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.00197	0.00317	CcSEcCtD
Nitisinone—HPD—Metabolism—UCP2—type 2 diabetes mellitus	0.00197	0.0089	CbGpPWpGaD
Nitisinone—HPD—Metabolism—UCP3—type 2 diabetes mellitus	0.00197	0.0089	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HSD11B1—type 2 diabetes mellitus	0.00197	0.0089	CbGpPWpGaD
Nitisinone—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00196	0.00314	CcSEcCtD
Nitisinone—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00195	0.00314	CcSEcCtD
Nitisinone—Dry skin—Orlistat—type 2 diabetes mellitus	0.00195	0.00313	CcSEcCtD
Nitisinone—Bronchitis—Gliclazide—type 2 diabetes mellitus	0.00195	0.00313	CcSEcCtD
Nitisinone—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00191	0.00306	CcSEcCtD
Nitisinone—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.0019	0.00305	CcSEcCtD
Nitisinone—Infection—Rosiglitazone—type 2 diabetes mellitus	0.00189	0.00304	CcSEcCtD
Nitisinone—Gastritis—Orlistat—type 2 diabetes mellitus	0.00188	0.00302	CcSEcCtD
Nitisinone—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.00188	0.00301	CcSEcCtD
Nitisinone—Tension—Glimepiride—type 2 diabetes mellitus	0.00187	0.003	CcSEcCtD
Nitisinone—Rash maculo-papular—Ramipril—type 2 diabetes mellitus	0.00187	0.003	CcSEcCtD
Nitisinone—Tension—Sitagliptin—type 2 diabetes mellitus	0.00186	0.00299	CcSEcCtD
Nitisinone—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00186	0.00299	CcSEcCtD
Nitisinone—HPD—Metabolism—PCK1—type 2 diabetes mellitus	0.00185	0.00837	CbGpPWpGaD
Nitisinone—Nervousness—Glimepiride—type 2 diabetes mellitus	0.00185	0.00297	CcSEcCtD
Nitisinone—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.00184	0.00296	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Losartan—type 2 diabetes mellitus	0.00184	0.00296	CcSEcCtD
Nitisinone—Nervousness—Sitagliptin—type 2 diabetes mellitus	0.00184	0.00296	CcSEcCtD
Nitisinone—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00184	0.00295	CcSEcCtD
Nitisinone—Leukopenia—Glipizide—type 2 diabetes mellitus	0.00183	0.00293	CcSEcCtD
Nitisinone—Dehydration—Metformin—type 2 diabetes mellitus	0.00182	0.00293	CcSEcCtD
Nitisinone—Bronchitis—Valsartan—type 2 diabetes mellitus	0.00179	0.00287	CcSEcCtD
Nitisinone—Hypoglycaemia—Losartan—type 2 diabetes mellitus	0.00178	0.00286	CcSEcCtD
Nitisinone—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00178	0.00285	CcSEcCtD
Nitisinone—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00178	0.00285	CcSEcCtD
Nitisinone—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.00175	0.00282	CcSEcCtD
Nitisinone—Agitation—Glimepiride—type 2 diabetes mellitus	0.00175	0.00281	CcSEcCtD
Nitisinone—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.00174	0.0028	CcSEcCtD
Nitisinone—HPD—Metabolism—HK1—type 2 diabetes mellitus	0.00173	0.00783	CbGpPWpGaD
Nitisinone—Headache—Tolbutamide—type 2 diabetes mellitus	0.00173	0.00278	CcSEcCtD
Nitisinone—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00172	0.00276	CcSEcCtD
Nitisinone—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.0017	0.00274	CcSEcCtD
Nitisinone—Epistaxis—Gliclazide—type 2 diabetes mellitus	0.0017	0.00273	CcSEcCtD
Nitisinone—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.0017	0.00273	CcSEcCtD
Nitisinone—Eye disorder—Glyburide—type 2 diabetes mellitus	0.00169	0.00271	CcSEcCtD
Nitisinone—Tension—Bromocriptine—type 2 diabetes mellitus	0.00169	0.00271	CcSEcCtD
Nitisinone—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.00168	0.00271	CcSEcCtD
Nitisinone—Gastroenteritis—Ramipril—type 2 diabetes mellitus	0.00168	0.0027	CcSEcCtD
Nitisinone—HPD—Metabolism—HSD3B2—type 2 diabetes mellitus	0.00167	0.00757	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GCKR—type 2 diabetes mellitus	0.00167	0.00757	CbGpPWpGaD
Nitisinone—HPD—Metabolism—KCNJ11—type 2 diabetes mellitus	0.00167	0.00757	CbGpPWpGaD
Nitisinone—HPD—Metabolism—LPA—type 2 diabetes mellitus	0.00167	0.00757	CbGpPWpGaD
Nitisinone—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00268	CcSEcCtD
Nitisinone—Hepatic failure—Ramipril—type 2 diabetes mellitus	0.00166	0.00267	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00165	0.00266	CcSEcCtD
Nitisinone—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00165	0.00265	CcSEcCtD
Nitisinone—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00165	0.00265	CcSEcCtD
Nitisinone—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.00165	0.00264	CcSEcCtD
Nitisinone—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00165	0.00264	CcSEcCtD
Nitisinone—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.00163	0.00262	CcSEcCtD
Nitisinone—HPD—Metabolism—ALDOB—type 2 diabetes mellitus	0.00161	0.00725	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00161	0.00258	CcSEcCtD
Nitisinone—Dry skin—Losartan—type 2 diabetes mellitus	0.0016	0.00256	CcSEcCtD
Nitisinone—Alopecia—Glyburide—type 2 diabetes mellitus	0.00159	0.00256	CcSEcCtD
Nitisinone—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00159	0.00256	CcSEcCtD
Nitisinone—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00159	0.00256	CcSEcCtD
Nitisinone—Infection—Pioglitazone—type 2 diabetes mellitus	0.00159	0.00255	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Ramipril—type 2 diabetes mellitus	0.00158	0.00254	CcSEcCtD
Nitisinone—Agitation—Bromocriptine—type 2 diabetes mellitus	0.00158	0.00254	CcSEcCtD
Nitisinone—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00157	0.00253	CcSEcCtD
Nitisinone—Headache—Tolazamide—type 2 diabetes mellitus	0.00157	0.00253	CcSEcCtD
Nitisinone—Epistaxis—Valsartan—type 2 diabetes mellitus	0.00156	0.00251	CcSEcCtD
Nitisinone—Headache—Linagliptin—type 2 diabetes mellitus	0.00156	0.0025	CcSEcCtD
Nitisinone—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00155	0.00249	CcSEcCtD
Nitisinone—Gastritis—Losartan—type 2 diabetes mellitus	0.00154	0.00247	CcSEcCtD
Nitisinone—Infection—Sitagliptin—type 2 diabetes mellitus	0.00154	0.00247	CcSEcCtD
Nitisinone—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.00153	0.00246	CcSEcCtD
Nitisinone—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00152	0.00244	CcSEcCtD
Nitisinone—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.00151	0.00243	CcSEcCtD
Nitisinone—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.0015	0.00242	CcSEcCtD
Nitisinone—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.0015	0.0024	CcSEcCtD
Nitisinone—HPD—Metabolism—GLP1R—type 2 diabetes mellitus	0.00149	0.00674	CbGpPWpGaD
Nitisinone—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00149	0.00239	CcSEcCtD
Nitisinone—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.00149	0.00239	CcSEcCtD
Nitisinone—Somnolence—Glipizide—type 2 diabetes mellitus	0.00148	0.00238	CcSEcCtD
Nitisinone—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.00148	0.00237	CcSEcCtD
Nitisinone—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.00147	0.00236	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00145	0.00233	CcSEcCtD
Nitisinone—Bronchitis—Losartan—type 2 diabetes mellitus	0.00145	0.00232	CcSEcCtD
Nitisinone—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00142	0.00229	CcSEcCtD
Nitisinone—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00141	0.00226	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC2A2—type 2 diabetes mellitus	0.00139	0.0063	CbGpPWpGaD
Nitisinone—Infection—Bromocriptine—type 2 diabetes mellitus	0.00139	0.00224	CcSEcCtD
Nitisinone—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.00139	0.00222	CcSEcCtD
Nitisinone—Tension—Gliclazide—type 2 diabetes mellitus	0.00138	0.00222	CcSEcCtD
Nitisinone—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00138	0.00222	CcSEcCtD
Nitisinone—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00138	0.00221	CcSEcCtD
Nitisinone—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00138	0.00221	CcSEcCtD
Nitisinone—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00137	0.0022	CcSEcCtD
Nitisinone—HPD—Metabolism—CPT1A—type 2 diabetes mellitus	0.00137	0.00617	CbGpPWpGaD
Nitisinone—HPD—Metabolism—MTR—type 2 diabetes mellitus	0.00137	0.00617	CbGpPWpGaD
Nitisinone—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00219	CcSEcCtD
Nitisinone—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00136	0.00219	CcSEcCtD
Nitisinone—Convulsion—Glyburide—type 2 diabetes mellitus	0.00136	0.00219	CcSEcCtD
Nitisinone—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00135	0.00216	CcSEcCtD
Nitisinone—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.00134	0.00216	CcSEcCtD
Nitisinone—HPD—Metabolism—NAMPT—type 2 diabetes mellitus	0.00134	0.00605	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GCK—type 2 diabetes mellitus	0.00133	0.00601	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HBA1—type 2 diabetes mellitus	0.00133	0.00601	CbGpPWpGaD
Nitisinone—HPD—Metabolism—LIPC—type 2 diabetes mellitus	0.00133	0.00601	CbGpPWpGaD
Nitisinone—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.00133	0.00214	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP11A1—type 2 diabetes mellitus	0.00132	0.00597	CbGpPWpGaD
Nitisinone—Gastritis—Ramipril—type 2 diabetes mellitus	0.00132	0.00212	CcSEcCtD
Nitisinone—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00132	0.00211	CcSEcCtD
Nitisinone—Alopecia—Valsartan—type 2 diabetes mellitus	0.00132	0.00211	CcSEcCtD
Nitisinone—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.0013	0.00209	CcSEcCtD
Nitisinone—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.0013	0.00209	CcSEcCtD
Nitisinone—Alopecia—Orlistat—type 2 diabetes mellitus	0.0013	0.00209	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC9A1—type 2 diabetes mellitus	0.0013	0.00587	CbGpPWpGaD
Nitisinone—Agitation—Gliclazide—type 2 diabetes mellitus	0.0013	0.00208	CcSEcCtD
Nitisinone—HPD—Metabolism—CETP—type 2 diabetes mellitus	0.00128	0.0058	CbGpPWpGaD
Nitisinone—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00127	0.00204	CcSEcCtD
Nitisinone—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00127	0.00204	CcSEcCtD
Nitisinone—Eye disorder—Metformin—type 2 diabetes mellitus	0.00127	0.00203	CcSEcCtD
Nitisinone—Epistaxis—Losartan—type 2 diabetes mellitus	0.00126	0.00203	CcSEcCtD
Nitisinone—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00126	0.00203	CcSEcCtD
Nitisinone—Headache—Repaglinide—type 2 diabetes mellitus	0.00126	0.00203	CcSEcCtD
Nitisinone—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00126	0.00202	CcSEcCtD
Nitisinone—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00125	0.00201	CcSEcCtD
Nitisinone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00125	0.002	CcSEcCtD
Nitisinone—Bronchitis—Ramipril—type 2 diabetes mellitus	0.00124	0.00199	CcSEcCtD
Nitisinone—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00123	0.00197	CcSEcCtD
Nitisinone—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00122	0.00197	CcSEcCtD
Nitisinone—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00122	0.00196	CcSEcCtD
Nitisinone—HPD—Metabolism—SREBF1—type 2 diabetes mellitus	0.00119	0.00539	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PSMD6—type 2 diabetes mellitus	0.00119	0.00539	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SNAP25—type 2 diabetes mellitus	0.00119	0.00539	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00119	0.00192	CcSEcCtD
Nitisinone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00119	0.00191	CcSEcCtD
Nitisinone—Pruritus—Glipizide—type 2 diabetes mellitus	0.00118	0.00189	CcSEcCtD
Nitisinone—HPD—Metabolism—CTGF—type 2 diabetes mellitus	0.00117	0.00529	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HMGCR—type 2 diabetes mellitus	0.00116	0.00524	CbGpPWpGaD
Nitisinone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00115	0.00184	CcSEcCtD
Nitisinone—Infection—Gliclazide—type 2 diabetes mellitus	0.00114	0.00184	CcSEcCtD
Nitisinone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00114	0.00183	CcSEcCtD
Nitisinone—HPD—Metabolism—ADRA2A—type 2 diabetes mellitus	0.00114	0.00513	CbGpPWpGaD
Nitisinone—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00113	0.00181	CcSEcCtD
Nitisinone—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00112	0.0018	CcSEcCtD
Nitisinone—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.00112	0.0018	CcSEcCtD
Nitisinone—Convulsion—Orlistat—type 2 diabetes mellitus	0.00111	0.00178	CcSEcCtD
Nitisinone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00111	0.00178	CcSEcCtD
Nitisinone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.0011	0.00177	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.0011	0.00176	CcSEcCtD
Nitisinone—Tension—Irbesartan—type 2 diabetes mellitus	0.00109	0.00176	CcSEcCtD
Nitisinone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00109	0.00175	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP2E1—type 2 diabetes mellitus	0.00109	0.00493	CbGpPWpGaD
Nitisinone—Epistaxis—Ramipril—type 2 diabetes mellitus	0.00108	0.00174	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00108	0.00174	CcSEcCtD
Nitisinone—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00108	0.00174	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP1A2—type 2 diabetes mellitus	0.00108	0.00488	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SLC2A1—type 2 diabetes mellitus	0.00108	0.00488	CbGpPWpGaD
Nitisinone—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00107	0.00172	CcSEcCtD
Nitisinone—Alopecia—Losartan—type 2 diabetes mellitus	0.00106	0.00171	CcSEcCtD
Nitisinone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00106	0.00171	CcSEcCtD
Nitisinone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00106	0.0017	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP3A4—type 2 diabetes mellitus	0.00105	0.00475	CbGpPWpGaD
Nitisinone—Infection—Valsartan—type 2 diabetes mellitus	0.00105	0.00169	CcSEcCtD
Nitisinone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00105	0.00168	CcSEcCtD
Nitisinone—Headache—Glipizide—type 2 diabetes mellitus	0.00104	0.00168	CcSEcCtD
Nitisinone—Infection—Orlistat—type 2 diabetes mellitus	0.00104	0.00167	CcSEcCtD
Nitisinone—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00104	0.00166	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC2A4—type 2 diabetes mellitus	0.00103	0.00467	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GCG—type 2 diabetes mellitus	0.00103	0.00467	CbGpPWpGaD
Nitisinone—Tension—Losartan—type 2 diabetes mellitus	0.00103	0.00165	CcSEcCtD
Nitisinone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00103	0.00165	CcSEcCtD
Nitisinone—Agitation—Irbesartan—type 2 diabetes mellitus	0.00102	0.00164	CcSEcCtD
Nitisinone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00102	0.00164	CcSEcCtD
Nitisinone—Nervousness—Losartan—type 2 diabetes mellitus	0.00102	0.00163	CcSEcCtD
Nitisinone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00101	0.00163	CcSEcCtD
Nitisinone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00101	0.00163	CcSEcCtD
Nitisinone—Headache—Pioglitazone—type 2 diabetes mellitus	0.001	0.00161	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000998	0.0016	CcSEcCtD
Nitisinone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000997	0.0016	CcSEcCtD
Nitisinone—Headache—Glimepiride—type 2 diabetes mellitus	0.000974	0.00156	CcSEcCtD
Nitisinone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000971	0.00156	CcSEcCtD
Nitisinone—Agitation—Losartan—type 2 diabetes mellitus	0.000963	0.00155	CcSEcCtD
Nitisinone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000959	0.00154	CcSEcCtD
Nitisinone—Infection—Metformin—type 2 diabetes mellitus	0.000957	0.00154	CcSEcCtD
Nitisinone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000943	0.00151	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000941	0.00151	CcSEcCtD
Nitisinone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000941	0.00151	CcSEcCtD
Nitisinone—Somnolence—Valsartan—type 2 diabetes mellitus	0.00094	0.00151	CcSEcCtD
Nitisinone—Leukopenia—Losartan—type 2 diabetes mellitus	0.000938	0.00151	CcSEcCtD
Nitisinone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000935	0.0015	CcSEcCtD
Nitisinone—Alopecia—Ramipril—type 2 diabetes mellitus	0.000912	0.00147	CcSEcCtD
Nitisinone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00091	0.00146	CcSEcCtD
Nitisinone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000907	0.00146	CcSEcCtD
Nitisinone—Infection—Irbesartan—type 2 diabetes mellitus	0.000903	0.00145	CcSEcCtD
Nitisinone—HPD—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000892	0.00403	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GNB3—type 2 diabetes mellitus	0.000892	0.00403	CbGpPWpGaD
Nitisinone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00089	0.00143	CcSEcCtD
Nitisinone—HPD—Metabolism—HMOX1—type 2 diabetes mellitus	0.000888	0.00401	CbGpPWpGaD
Nitisinone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000883	0.00142	CcSEcCtD
Nitisinone—Tension—Ramipril—type 2 diabetes mellitus	0.000882	0.00142	CcSEcCtD
Nitisinone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000878	0.00141	CcSEcCtD
Nitisinone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000877	0.00141	CcSEcCtD
Nitisinone—HPD—Metabolism—CAT—type 2 diabetes mellitus	0.000876	0.00396	CbGpPWpGaD
Nitisinone—Nervousness—Ramipril—type 2 diabetes mellitus	0.000873	0.0014	CcSEcCtD
Nitisinone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000865	0.00139	CcSEcCtD
Nitisinone—Somnolence—Metformin—type 2 diabetes mellitus	0.000856	0.00138	CcSEcCtD
Nitisinone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000854	0.00137	CcSEcCtD
Nitisinone—HPD—Metabolism—APOB—type 2 diabetes mellitus	0.00085	0.00384	CbGpPWpGaD
Nitisinone—Infection—Losartan—type 2 diabetes mellitus	0.00085	0.00136	CcSEcCtD
Nitisinone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000837	0.00135	CcSEcCtD
Nitisinone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000836	0.00134	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTM1—type 2 diabetes mellitus	0.000827	0.00374	CbGpPWpGaD
Nitisinone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000826	0.00133	CcSEcCtD
Nitisinone—Agitation—Ramipril—type 2 diabetes mellitus	0.000826	0.00133	CcSEcCtD
Nitisinone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000814	0.00131	CcSEcCtD
Nitisinone—HPD—Metabolism—LPL—type 2 diabetes mellitus	0.000812	0.00367	CbGpPWpGaD
Nitisinone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000808	0.0013	CcSEcCtD
Nitisinone—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000804	0.00129	CcSEcCtD
Nitisinone—Headache—Glyburide—type 2 diabetes mellitus	0.000803	0.00129	CcSEcCtD
Nitisinone—HPD—Metabolism—ADCY5—type 2 diabetes mellitus	0.000795	0.00359	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GPX1—type 2 diabetes mellitus	0.000792	0.00358	CbGpPWpGaD
Nitisinone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000788	0.00126	CcSEcCtD
Nitisinone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000787	0.00126	CcSEcCtD
Nitisinone—Convulsion—Ramipril—type 2 diabetes mellitus	0.000779	0.00125	CcSEcCtD
Nitisinone—HPD—Metabolism—CD36—type 2 diabetes mellitus	0.000771	0.00349	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000762	0.00344	CbGpPWpGaD
Nitisinone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000761	0.00122	CcSEcCtD
Nitisinone—Somnolence—Losartan—type 2 diabetes mellitus	0.00076	0.00122	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00076	0.00122	CcSEcCtD
Nitisinone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000748	0.0012	CcSEcCtD
Nitisinone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000743	0.00119	CcSEcCtD
Nitisinone—Pruritus—Orlistat—type 2 diabetes mellitus	0.000739	0.00119	CcSEcCtD
Nitisinone—HPD—Metabolism—MTHFR—type 2 diabetes mellitus	0.000731	0.0033	CbGpPWpGaD
Nitisinone—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000724	0.00116	CcSEcCtD
Nitisinone—Headache—Gliclazide—type 2 diabetes mellitus	0.000721	0.00116	CcSEcCtD
Nitisinone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000718	0.00115	CcSEcCtD
Nitisinone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000718	0.00115	CcSEcCtD
Nitisinone—HPD—Metabolism—PPARA—type 2 diabetes mellitus	0.000717	0.00324	CbGpPWpGaD
Nitisinone—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000715	0.00115	CcSEcCtD
Nitisinone—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000712	0.00114	CcSEcCtD
Nitisinone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000699	0.00112	CcSEcCtD
Nitisinone—HPD—Metabolism—AGT—type 2 diabetes mellitus	0.000695	0.00314	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CALM1—type 2 diabetes mellitus	0.000683	0.00309	CbGpPWpGaD
Nitisinone—Pruritus—Metformin—type 2 diabetes mellitus	0.000681	0.00109	CcSEcCtD
Nitisinone—HPD—Metabolism—APOE—type 2 diabetes mellitus	0.000681	0.00307	CbGpPWpGaD
Nitisinone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000676	0.00109	CcSEcCtD
Nitisinone—HPD—Metabolism—APOA1—type 2 diabetes mellitus	0.000673	0.00304	CbGpPWpGaD
Nitisinone—Headache—Valsartan—type 2 diabetes mellitus	0.000662	0.00106	CcSEcCtD
Nitisinone—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000659	0.00106	CcSEcCtD
Nitisinone—Headache—Orlistat—type 2 diabetes mellitus	0.000655	0.00105	CcSEcCtD
Nitisinone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000652	0.00105	CcSEcCtD
Nitisinone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000643	0.00103	CcSEcCtD
Nitisinone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000622	0.000999	CcSEcCtD
Nitisinone—Pruritus—Losartan—type 2 diabetes mellitus	0.000605	0.000972	CcSEcCtD
Nitisinone—Headache—Metformin—type 2 diabetes mellitus	0.000603	0.000969	CcSEcCtD
Nitisinone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.0006	0.000963	CcSEcCtD
Nitisinone—HPD—Metabolism—PPARG—type 2 diabetes mellitus	0.000593	0.00268	CbGpPWpGaD
Nitisinone—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000585	0.00094	CcSEcCtD
Nitisinone—HPD—Metabolism—INS—type 2 diabetes mellitus	0.000581	0.00263	CbGpPWpGaD
Nitisinone—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00058	0.000931	CcSEcCtD
Nitisinone—Headache—Irbesartan—type 2 diabetes mellitus	0.000569	0.000914	CcSEcCtD
Nitisinone—Headache—Losartan—type 2 diabetes mellitus	0.000536	0.000861	CcSEcCtD
Nitisinone—HPD—Metabolism—ALB—type 2 diabetes mellitus	0.000533	0.00241	CbGpPWpGaD
Nitisinone—Pruritus—Ramipril—type 2 diabetes mellitus	0.000519	0.000833	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3R1—type 2 diabetes mellitus	0.00051	0.0023	CbGpPWpGaD
Nitisinone—HPD—Metabolism—NOS3—type 2 diabetes mellitus	0.00051	0.0023	CbGpPWpGaD
Nitisinone—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000502	0.000806	CcSEcCtD
Nitisinone—HPD—Metabolism—PTGS2—type 2 diabetes mellitus	0.000466	0.00211	CbGpPWpGaD
Nitisinone—Headache—Ramipril—type 2 diabetes mellitus	0.000459	0.000738	CcSEcCtD
Nitisinone—HPD—Metabolism—AKT1—type 2 diabetes mellitus	0.000234	0.00106	CbGpPWpGaD
